Diabetic autonomic neuropathies as a major risk factor for silent myocardial ischemia and infarction: a literature review

  • Authors

    • Kindo Shek Kamara Cardiology Department, Zhongnan Hospital of Wuhan University. Wuhan, Hubei, China.
    • Chuan Feng Tong Cardiology Department, Zhongnan Hospital of Wuhan University. Wuhan, Hubei, China.
    2020-09-19
    https://doi.org/10.14419/ijm.v8i2.31031
  • Diabetes Mellitus, Myocardial Infarction, Coronary Artery Disease, Diabetic Neuropathy, Diabetic Autonomic Neuropathy, Cardiac Autonomic Neuropathy.

  • Abstract

    A substantial number of myocardial infarctions (MIs) are asymptomatic or associated with mi-nor and atypical symptoms. These symptoms are often atypical or even absent, especially in di-abetic patients. A number of studies on this topic have shown that in the presence of myocardial ischemia and infarction, diabetic patients report angina less frequently than non-diabetic pa-tients. In this article review, we researched several published articles written about this subject and investigated the relationship between Diabetes Mellitus (DM) in patients and the occur-rence of silent myocardial ischemia and infarction due to the onset of diabetic neuropathy (DN), which is brought about by prolonged diabetes. Based on our research of published articles and studies, we found overwhelming evidence that supports the fact that diabetic autonomic neu-ropathy (DAN) is a major contributing factor in the morbidity of silent myocardial ischemia and infarction among patients suffering from DM.

     

     


  • References

    1. [1] Agashe, S., & Petak, S. (2018). Cardiac Autonomic Neuropathy in Diabetes Mellitus. Methodist DeBakey Cardiovascular Journal, 14(4), 251–256.

      [2] Airaksinen, K. E. (2001). Silent coronary artery disease in diabetes—A feature of autonomic neuropathy or accelerated atherosclerosis? Diabetologia, 44(2), 259–266. https://doi.org/10.1007/s001250051609.

      [3] Amara, F., Hafez, S., Orabi, A., El Etriby, A., Abdel Rahim, A. A., Zakaria, E., Koura, F., Talaat, F. M., Gawish, H., Attia, I., Abdel Aziz, M. F., El Hefnawy, M. H. M. F., Kamar, M., Halawa, M. R., El-Sayed, M. S., El Kafrawy, N. A., Khalil, S. H. A., & Assaad, S. N. (2019). Review of Diabetic Polyneuropathy: Pathogenesis, Diagnosis and Management According to the Consensus of Egyptian Experts. Current Diabetes Reviews, 15(4), 340–345. https://doi.org/10.2174/1573399815666190226150402.

      [4] Ambepityia, G., Kopelman, P. G., Ingram, D., Swash, M., Mills, P. G., & Timmis, A. D. (1990). Exertional myocardial ischemia in diabetes: A quantitative analysis of anginal perceptual threshold and the influence of autonomic function. Journal of the American College of Cardiology, 15(1), 72–77. https://doi.org/10.1016/0735-1097(90)90178-R.

      [5] Association, A. D. (2009). Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 32(Supplement 1), S62–S67. https://doi.org/10.2337/dc09-S062.

      [6] Autonomic neuropathy: MedlinePlus Medical Encyclopedia. (n.d.). Retrieved 18 July 2020, from https://medlineplus.gov/ency/article/000776.htm.

      [7] Bradley, R. F., & Schonfeld, A. (1962). Diminished pain in diabetic patients with acute myocardial infarction. Geriatrics, 17, 322–326.

      [8] Caracciolo, E. A., Chaitman, B. R., Forman, S. A., Stone, P. H., Bourassa, M. G., Sopko, G., Geller, N. L., & Conti, C. R. (1996). Diabetics with coronary disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients. An ACIP database study. ACIP Investigators. Asymptomatic Cardiac Ischemia Pilot Investigators. Circulation, 93(12), 2097–2105. https://doi.org/10.1161/01.CIR.93.12.2097.

      [9] Diabetic Neuropathy | NIDDK. (n.d.). National Institute of Diabetes and Digestive and Kidney Diseases. Retrieved 18 July 2020, from https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/nerve-damage-diabetic-neuropathies.

      [10] Diabetic neuropathy—Symptoms and causes. (n.d.). Mayo Clinic. Retrieved 18 July 2020, from https://www.mayoclinic.org/diseases-conditions/diabetic-neuropathy/symptoms-causes/syc-20371580.

      [11] Dörr, M. (2010). Silent myocardial infarction: The risk beyond the first admission. Heart, 96(18), 1434–1435. https://doi.org/10.1136/hrt.2010.201384.

      [12] Faerman, I., Faccio, E., Milei, J., Nuñez, R., Jadzinsky, M., Fox, D., & Rapaport, M. (1977). Autonomic neuropathy and painless myocardial infarction in diabetic patients. Histologic evidence of their relationship. Diabetes, 26(12), 1147–1158. https://doi.org/10.2337/diab.26.12.1147.

      [13] Freeman, R. (2014). Chapter 6—Diabetic autonomic neuropathy. In D. W. Zochodne & R. A. Malik (Eds.), Handbook of Clinical Neurology (Vol. 126, pp. 63–79). Elsevier. https://doi.org/10.1016/B978-0-444-53480-4.00006-0.

      [14] Gandhi, J., Dagur, G., Warren, K., Smith, N. L., & Khan, S. A. (2017). Genitourinary Complications of Diabetes Mellitus: An Overview of Pathogenesis, Evaluation, and Management. Current Diabetes Reviews, 13(5), 498–518. https://doi.org/10.2174/1573399812666161019162747.

      [15] Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998). Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. New England Journal of Medicine, 339(4), 229–234. https://doi.org/10.1056/NEJM199807233390404.

      [16] Hill, M. D. (2014). Stroke and diabetes mellitus. Handbook of Clinical Neurology, 126, 167–174. https://doi.org/10.1016/B978-0-444-53480-4.00012-6.

      [17] Hume, L., Oakley, G. D., Boulton, A. J., Hardisty, C., & Ward, J. D. (1986). Asymptomatic myocardial ischemia in diabetes and its relationship to diabetic neuropathy: An exercise electrocardiography study in middle-aged diabetic men. Diabetes Care, 9(4), 384–388. https://doi.org/10.2337/diacare.9.4.384.

      [18] Kallinikou, D., Soldatou, A., Tsentidis, C., Louraki, M., Kanaka-Gantenbein, C., Kanavakis, E., & Karavanaki, K. (2019). Diabetic neuropathy in children and adolescents with type 1 diabetes mellitus: Diagnosis, pathogenesis, and associated genetic markers. Diabetes/Metabolism Research and Reviews, 35(7), e3178. https://doi.org/10.1002/dmrr.3178.

      [19] Koistinen, M. J., Airaksinen, K. E., Huikuri, H. V., Pirttiaho, H., Linnaluoto, M. K., Ikäheimo, M. J., & Takkunen, J. T. (1992). Asymptomatic coronary artery disease in diabetes: Associated with autonomic neuropathy? Acta Diabetologica, 28(3–4), 199–202. https://doi.org/10.1007/BF00778998.

      [20] Langer, A., Freeman, M. R., Josse, R. G., Steiner, G., & Armstrong, P. W. (1991). Detection of silent myocardial ischemia in diabetes mellitus. The American Journal of Cardiology, 67(13), 1073–1078. https://doi.org/10.1016/0002-9149(91)90868-L.

      [21] Marchant, B., Umachandran, V., Stevenson, R., Kopelman, P. G., & Timmis, A. D. (1993). Silent myocardial ischemia: Role of subclinical neuropathy in patients with and without diabetes. Journal of the American College of Cardiology, 22(5), 1433–1437. https://doi.org/10.1016/0735-1097(93)90554-E.

      [22] Margolis, J. R., Kannel, W. S., Feinleib, M., Dawber, T. R., & McNamara, P. M. (1973). Clinical features of unrecognized myocardial infarction--silent and symptomatic. Eighteen year follow-up: The Framingham study. The American Journal of Cardiology, 32(1), 1–7. https://doi.org/10.1016/S0002-9149(73)80079-7.

      [23] Miettinen, H., Lehto, S., Salomaa, V., Mähönen, M., Niemelä, M., Haffner, S. M., Pyörälä, K., Tuomilehto, J., & Group, T. F. M. I. R. S. (1998). Impact of Diabetes on Mortality After the First Myocardial Infarction. Diabetes Care, 21(1), 69–75. https://doi.org/10.2337/diacare.21.1.69.

      [24] Murray, D. P., O’Brien, T., Mulrooney, R., & O’Sullivan, D. J. (1990). Autonomic dysfunction and silent myocardial ischaemia on exercise testing in diabetes mellitus. Diabetic Medicine: A Journal of the British Diabetic Association, 7(7), 580–584. https://doi.org/10.1111/j.1464-5491.1990.tb01452.x.

      [25] Niakan, E., Harati, Y., Rolak, L. A., Comstock, J. P., & Rokey, R. (1986). Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy. Archives of Internal Medicine, 146(11), 2229–2230. https://doi.org/10.1001/archinte.1986.00360230169023.

      [26] O’Sullivan, J. J., Conroy, R. M., MacDonald, K., McKenna, T. J., & Maurer, B. J. (1991). Silent ischaemia in diabetic men with autonomic neuropathy. British Heart Journal, 66(4), 313–315. https://doi.org/10.1136/hrt.66.4.313.

      [27] Serhiyenko, V. A., & Serhiyenko, A. A. (2018). Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment. World Journal of Diabetes, 9(1), 1–24. https://doi.org/10.4239/wjd.v9.i1.1.

      [28] Sukhija, R., Dhanwal, D., Gambhir, D. S., & Dewan, R. (2000). Silent myocardial ischaemia in patients with type II diabetes mellitus and its relation with autonomic dysfunction. Indian Heart Journal, 52(5), 540–546.

      [29] Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg, P. G., James, S. K., Atar, D., Badano, L. P., Blömstrom-Lundqvist, C., Borger, M. A., Di Mario, C., Dickstein, K., Ducrocq, G., Fernandez-Aviles, F., Gershlick, A. H., Giannuzzi, P., Halvorsen, S., Huber, K., Juni, P., Kastrati, A., Knuuti, J., Lenzen, M. J., … Zahger, D. (2012). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal, 33(20), 2569–2619. https://doi.org/10.1093/eurheartj/ehs215.

      [30] Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., White, H. D., & Infarction, T. E. G. on behalf of the J. E. S. of C. (ESC)/American C. of C. (ACC)/American H. A. (AHA)/World H. F. (WHF) T. F. for the U. D. of M. (2018). Fourth Universal Definition of Myocardial Infarction (2018). Journal of the American College of Cardiology, 72(18), 2231–2264. https://doi.org/10.1016/j.jacc.2018.08.1038.

      [31] Thygesen Kristian, Alpert Joseph S., White Harvey D., null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, & null null. (2007). Universal Definition of Myocardial Infarction. Circulation, 116(22), 2634–2653. https://doi.org/10.1161/CIRCULATIONAHA.107.187397.

      [32] Vinik, A. I., Nevoret, M.-L., Casellini, C., & Parson, H. (2013). Diabetic neuropathy. Endocrinology and Metabolism Clinics of North America, 42(4), 747–787. https://doi.org/10.1016/j.ecl.2013.06.001.

      [33] Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., Abraham, J., Ackerman, I., Aggarwal, R., Ahn, S. Y., Ali, M. K., AlMazroa, M. A., Alvarado, M., Anderson, H. R., Anderson, L. M., … Murray, C. J. (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 380(9859), 2163–2196. https://doi.org/10.1016/S0140-6736(12)61729-2.

      [34] Wackers, F. J. T., Young, L. H., Inzucchi, S. E., Chyun, D. A., Davey, J. A., Barrett, E. J., Taillefer, R., Wittlin, S. D., Heller, G. V., Filipchuk, N., Engel, S., Ratner, R. E., Iskandrian, A. E., & Detection of Ischemia in Asymptomatic Diabetics Investigators. (2004). Detection of silent myocardial ischemia in asymptomatic diabetic subjects: The DIAD study. Diabetes Care, 27(8), 1954–1961. https://doi.org/10.2337/diacare.27.8.1954.

      [35] WHO | About diabetes. (2014, March 31). https://web.archive.org/web/20140331094533/http://www.who.int/diabetes/action_online/basics/en/

      [36] Zellweger, M. J., Hachamovitch, R., Kang, X., Hayes, S. W., Friedman, J. D., Germano, G., Pfisterer, M. E., & Berman, D. S. (2004). Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. European Heart Journal, 25(7), 543–550. https://doi.org/10.1016/j.ehj.2004.02.013.

      [37] Ziegler, D. (1994). Diabetic cardiovascular autonomic neuropathy: Prognosis, diagnosis and treatment. Diabetes/Metabolism Reviews, 10(4), 339–383. https://doi.org/10.1002/dmr.5610100403.

  • Downloads

  • How to Cite

    Shek Kamara, K., & Feng Tong, C. (2020). Diabetic autonomic neuropathies as a major risk factor for silent myocardial ischemia and infarction: a literature review. International Journal of Medicine, 8(2), 19-24. https://doi.org/10.14419/ijm.v8i2.31031

    Received date: 2020-07-22

    Accepted date: 2020-08-23

    Published date: 2020-09-19